Should you buy Dolby Laboratories stock? (NYSE:DLB). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that Dolby Laboratories can grow its free cash at a rate of about 3%. That's positive!
(Dolby Laboratories stock price per share)
||DLB Fair Price
(based on intrinsic value)
|DLB Safety Price (based on a variable margin of safety)||$34.13|
|PE Ratio versus Sector||94% higher than other Technology stocks|
|PE Ratio versus Industry||478% higher than other Unknown stocks|
|Free Cash Flow Jitter||16%|
|Dividend Yield||1%||Shares Shorted||796,600|
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 796,600 shares shorted. With 64,456,151 shares available for purchase and an average trading volume over the past 10 trading days of 729,814, it would take at least 1.092 days for all of the short holders to cover their shorts.
We believe that Dolby Laboratories may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Dolby Laboratories looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Does Dolby Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles